253 related articles for article (PubMed ID: 32513667)
41. Retinal pigment epithelium hyperplasia overlying pigment epithelial detachment in age-related macular degeneration can masquerade as neovascularization on optical coherence tomography angiography.
Chen L; Zhang X; Gan Y; Liu B; Zhang Y; Wen F
Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2283-2291. PubMed ID: 30229304
[TBL] [Abstract][Full Text] [Related]
42. Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration.
Schütze C; Wedl M; Baumann B; Pircher M; Hitzenberger CK; Schmidt-Erfurth U
Am J Ophthalmol; 2015 Jun; 159(6):1100-1114.e1. PubMed ID: 25769245
[TBL] [Abstract][Full Text] [Related]
43. [Optical coherence tomography angiography in the diagnosis of neovascular age-related macular degeneration].
Shaimov TB; Panova IE; Shaimov RB; Shaimovа VA; Shai Mova TA; Fomin AV; Shaimov TB; Panova IE; Shaimov RB; Shaimova VA; Shaimova TA; Fomin AV
Vestn Oftalmol; 2015; 131(5):4-13. PubMed ID: 26845866
[TBL] [Abstract][Full Text] [Related]
44. MACULAR TELANGIECTASIA TYPE 2: Acircularity Index and Quantitative Assessment of Foveal Avascular Zone Using Optical Coherence Tomography Angiography.
Ersoz MG; Hocaoglu M; Sayman Muslubas I; Arf S; Karacorlu M
Retina; 2020 Jun; 40(6):1132-1139. PubMed ID: 30893277
[TBL] [Abstract][Full Text] [Related]
45. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
46. CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.
Matet A; Yzer S; Chew EY; Daruich A; Behar-Cohen F; Spaide RF
Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S67-S78. PubMed ID: 29016451
[TBL] [Abstract][Full Text] [Related]
47. Early deterioration in ellipsoid zone in eyes with non-neovascular age-related macular degeneration.
Toprak I; Yaylalı V; Yildirim C
Int Ophthalmol; 2017 Aug; 37(4):801-806. PubMed ID: 27591785
[TBL] [Abstract][Full Text] [Related]
48. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
[TBL] [Abstract][Full Text] [Related]
49. CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.
Leung I; Sallo FB; Bonelli R; Clemons TE; Pauleikhoff D; Chew EY; Bird AC; Peto T;
Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S43-S50. PubMed ID: 29095354
[TBL] [Abstract][Full Text] [Related]
50. Multimodal imaging of early stage 1 type 3 neovascularization with simultaneous eye-tracked spectral-domain optical coherence tomography and high-speed real-time angiography.
Querques G; Souied EH; Freund KB
Retina; 2013 Oct; 33(9):1881-7. PubMed ID: 23644560
[TBL] [Abstract][Full Text] [Related]
51. Comparison of Short-Term Choroidal Thickness and Retinal Morphological Changes after Intravitreal Anti-VEGF Therapy with Ranibizumab or Aflibercept in Treatment-Naive Eyes.
Gharbiya M; Giustolisi R; Marchiori J; Bruscolini A; Mallone F; Fameli V; Nebbioso M; Abdolrahimzadeh S
Curr Eye Res; 2018 Mar; 43(3):391-396. PubMed ID: 29166140
[TBL] [Abstract][Full Text] [Related]
52. Comparison of Optical Coherence Tomography With Fundus Photographs, Fluorescein Angiography, and Histopathologic Analysis in Assessing Coats Disease.
Ong SS; Cummings TJ; Vajzovic L; Mruthyunjaya P; Toth CA
JAMA Ophthalmol; 2019 Feb; 137(2):176-183. PubMed ID: 30476946
[TBL] [Abstract][Full Text] [Related]
53. Subinternal Limiting Membrane Neovascularization in Macular Telangiectasia.
Ayachit A; Fatima F; Salvi R
Ophthalmol Retina; 2022 Jan; 6(1):42. PubMed ID: 34996539
[No Abstract] [Full Text] [Related]
54. IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Cheung CMG; Yanagi Y; Akiba M; Tan A; Mathur R; Chan CM; Yeo I; Wong TY
Retina; 2019 Sep; 39(9):1655-1663. PubMed ID: 29927796
[TBL] [Abstract][Full Text] [Related]
55. Machine Learning to Analyze the Prognostic Value of Current Imaging Biomarkers in Neovascular Age-Related Macular Degeneration.
Schmidt-Erfurth U; Bogunovic H; Sadeghipour A; Schlegl T; Langs G; Gerendas BS; Osborne A; Waldstein SM
Ophthalmol Retina; 2018 Jan; 2(1):24-30. PubMed ID: 31047298
[TBL] [Abstract][Full Text] [Related]
56. Refining Coats' disease by ultra-widefield imaging and optical coherence tomography angiography.
Rabiolo A; Marchese A; Sacconi R; Cicinelli MV; Grosso A; Querques L; Querques G; Bandello F
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1881-1890. PubMed ID: 28875282
[TBL] [Abstract][Full Text] [Related]
57. Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration.
Rosenfeld PJ
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT14-26. PubMed ID: 27409464
[TBL] [Abstract][Full Text] [Related]
58. Correlation between macular structure and function in patients with age-related macular degeneration treated with intravitreal ranibizumab: 12-month-results.
Nishimura T; Machida S
Jpn J Ophthalmol; 2019 Jan; 63(1):90-99. PubMed ID: 30470956
[TBL] [Abstract][Full Text] [Related]
59. Spectral-Domain Optical Coherence Tomography Analysis of Fibrotic Lesions in Neovascular Age-Related Macular Degeneration.
Souied EH; Addou-Regnard M; Ohayon A; Semoun O; Querques G; Blanco-Garavito R; Bunod R; Jung C; Sikorav A; Miere A
Am J Ophthalmol; 2020 Jun; 214():151-171. PubMed ID: 32112774
[TBL] [Abstract][Full Text] [Related]
60. Retinal vascular layers in macular telangiectasia type 2 imaged by optical coherence tomographic angiography.
Spaide RF; Klancnik JM; Cooney MJ
JAMA Ophthalmol; 2015 Jan; 133(1):66-73. PubMed ID: 25317692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
